BIOCRYST PHARMACEUTICALS INC Quarterly Interest Expense in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q1 2011 to Q2 2024.
  • Biocryst Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2024 was $24.7M, a 14.5% decline year-over-year.
  • Biocryst Pharmaceuticals Inc Interest Expense for the twelve months ending June 30, 2024 was $101M, a 5.93% decline year-over-year.
  • Biocryst Pharmaceuticals Inc annual Interest Expense for 2023 was $108M, a 9.23% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Interest Expense for 2022 was $99.1M, a 67.1% increase from 2021.
  • Biocryst Pharmaceuticals Inc annual Interest Expense for 2021 was $59.3M, a 309% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $101M $24.7M -$4.18M -14.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $105M $24.5M -$2.89M -10.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $108M $24.6M -$1.88M -7.09% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $110M $27.3M +$2.57M +10.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $108M $28.9M +$4.89M +20.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $103M $27.4M +$3.56M +14.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $99.1M $26.5M +$7.68M +40.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $91.4M $24.8M +$10.7M +75.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $80.8M $24M +$10.5M +78% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $70.2M $23.8M +$10.9M +84.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $59.3M $18.8M +$13.2M +235% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $46.1M $14.1M +$11.2M +382% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $34.9M $13.5M +$10.6M +362% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $24.4M $12.9M +$9.86M +323% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $14.5M $5.61M +$2.52M +81.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $12M $2.93M -$117K -3.84% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $12.1M $2.92M -$117K -3.86% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $12.2M $3.05M +$321K +11.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $11.9M $3.09M +$673K +27.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $11.2M $3.04M +$698K +29.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $10.5M $3.04M +$840K +38.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $9.68M $2.73M +$505K +22.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $9.18M $2.41M +$183K +8.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $8.99M $2.35M +$206K +9.63% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $8.79M $2.2M +$101K +4.82% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $8.69M $2.22M +$121K +5.76% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $8.57M $2.23M +$100K +4.69% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q3 2017 $8.47M $2.14M +$675K +46.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $7.79M $2.09M +$673K +47.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $7.12M $2.1M +$630K +42.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $6.49M $2.13M +$793K +59.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $5.69M $1.47M +$224K +18.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $5.47M $1.42M +$115K +8.81% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $5.36M $1.47M +$155K +11.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $5.2M $1.34M +$24K +1.83% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $5.18M $1.24M +$24K +1.97% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $5.15M $1.31M +$81K +6.61% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $5.07M $1.32M +$73K +5.88% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $5M $1.31M +$72K +5.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $4.93M $1.22M +$26K +2.18% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $4.9M $1.23M +$60K +5.15% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $4.84M $1.24M +$62K +5.25% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $4.78M $1.24M +$62K +5.25% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $4.72M $1.19M +$25K +2.14% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $4.69M $1.17M +$5K +0.43% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $4.69M $1.18M +$20K +1.72% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $4.67M $1.18M +$20K +1.72% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $4.65M $1.17M +$6K +0.52% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $4.64M $1.16M -$6K -0.52% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $4.65M $1.16M +$872K +303% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $3.77M $1.16M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-10
Q3 2011 $1.16M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $1.17M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $288K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.